Skandinaviska Enskilda Banken (SEB)’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12M Sell
552,700
-234,200
-30% -$5.08M 0.05% 263
2025
Q1
$19.1M Buy
786,900
+55,000
+8% +$1.33M 0.09% 181
2024
Q4
$15.4M Buy
731,900
+312,000
+74% +$6.57M 0.07% 208
2024
Q3
$8.35M Buy
+419,900
New +$8.35M 0.04% 302